Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 3,948 shares at $60.83 ($240K) on 2025-03-24, disclosed to the SEC on 2025-03-26.
Scheduled sale ($240k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.83 | 1,974 | $120K | 50.0% |
| 2 | $60.83 | 1,974 | $120K | 50.0% |
| Total | $60.83 avg | 3,948 | $240K | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |